An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy

Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with a variable clinical course. Novel biomarkers discovered over the past 20 years have revolutionized the way clinicians approach prognostication and treatment especially in the chemotherapy-free era. Herein, we review the best establis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Jared A., Bomben, Riccardo, Pozzo, Federico, Tissino, Erika, Härzschel, Andrea, Hartmann, Tanja Nicole, Zucchetto, Antonella, Gattei, Valter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226446/
https://www.ncbi.nlm.nih.gov/pubmed/32272636
http://dx.doi.org/10.3390/cancers12040894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226446/
https://www.ncbi.nlm.nih.gov/pubmed/32272636
http://dx.doi.org/10.3390/cancers12040894

Ejemplares similares